The U.S. Food and Drug Administration has approved a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity. The FDA had previously approved 2 mg and 4 mg naloxone nasal spray products. Naloxone is a medicine that can be administered by individuals with or … [Read more...] about FDA Approves Higher Dosage of Naloxone Nasal Spray
Community Medical Services Reaches Out To Harm Reduction
Community Medical Services (CMS), which opened two new opioid treatment programs (OTPs) in Wisconsin and Arizona recently, is the first program in the country to open “Opioid Treatment on Demand” centers 24 hours a day, 7 days a week. Reaching out to harm reduction agencies is a key focus of CMS’ work, making sure clients know that treatment is available. "There is … [Read more...] about Community Medical Services Reaches Out To Harm Reduction
Flaws In Idea Of Expanding Access To Methadone Via FQHCs And Chain Pharmacy
A recent study hypothesized that distribution of methadone in Ohio via Federally Qualified Health Centers (FQHCs0and pharmacies left out so many realities facing methadone treatment in the United States. The study, based on “geospatial” research, looked specifically at how close patients are via zip code to opioid treatment programs (OTPs), FQHCs, and pharmacies. Among these … [Read more...] about Flaws In Idea Of Expanding Access To Methadone Via FQHCs And Chain Pharmacy
New OTP in Tennessee Opens
The Talbott Legacy Centers (TLC) announced the opening of a new opioid treatment program (OTP) in Maryville, Tennessee in April. With service delivery starting April 7, the program will include comprehensive, nonresidential treatment services. Benjamin M. Roe, M.D. is the medical director. Many residents of Blount County, where the OTP is located, already know Dr. Roe … [Read more...] about New OTP in Tennessee Opens
X-waiver Changes Progressing Through Congress Amid Some Concerns From OTPs And Patients
Three bills going through Congress would change the way buprenorphine treatment is delivered, mainly eliminating the x-waiver, the training required for the special Drug Enforcement Administration (DEA) license allowing the dispensing of the medication for opioid use disorders (OUDs). TREATS Act The Telehealth Response for E-prescribing Addiction Therapy Services (TREATS) … [Read more...] about X-waiver Changes Progressing Through Congress Amid Some Concerns From OTPs And Patients
